TTK Healthcare Limited — Others, 21-03-2025: Change in Director(s)

TTK Healthcare has announced a board meeting outcome highlighting the redesignation of Mr. S Kalyanaraman from Wholetime Director & CEO to Managing Director & CEO, effective immediately and lasting until May 31, 2029, pending shareholder approval. The board also consented to a postal ballot for this approval, appointing a Scrutinizer to ensure transparency in the process. This leadership change is part of the company’s ongoing strategy to strengthen management, which may be viewed positively by investors, reflecting stability and continued expertise at the helm, albeit with a focus on shareholder engagement in decision-making.